Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers	Advanced Cancer	Recruiting	Phase 1	2025-04-25		NCT06188624

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	32

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of North Sichuan Medical College	Nanchong	China	13
Affiliated Zhongshan Hospital of Dalian University	Dalian	China	1
Chongqing University Cancer Hospital	Chongqing	China	54
Department of Medical Oncology, The First Hospital of China Medical University	Shenyang	China	1
Harbin Medical University Cancer Hospital	Harbin	China	102
Henan Cancer Hospital	Zhengzhou	China	57
Henan Provincine People's Hospital	Zhengzhou	China	1
Hunan Cancer Hospital	Changsha	China	123
Nanjing Drum Tower Hospital	Nanjing	China	52
Shanghai Pulmonary Hospital	Shanghai	China	72
Sun Yat-sen University Cancer Center	Guangzhou	China	315
The first affiliated hospital of Guangzhou medical university	Guangzhou	China	1
The First Affiliated Hospital of Xi'an Jiaotong University	Xi'an	China	1
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	125
The Second Xiangya Hospital of Central South University	Changsha	China	67
Tianjin Medical University Cancer Institute and Hospital	Tianjin	China	66
Yunnan Cancer Hospital	Kunming	China	44